Hematopoietic Stem Cell TransplantationStem Cell TransplantationStem CellsTransplantation, HomologousAdult Stem CellsEmbryonic Stem CellsTransplantation, AutologousHematopoietic Stem CellsPeripheral Blood Stem Cell TransplantationTransplantation ConditioningClone CellsCell DifferentiationGraft vs Host DiseaseHematologic NeoplasmsBone Marrow TransplantationLiver TransplantationTransplantation ChimeraMesenchymal Stem Cell TransplantationTreatment OutcomeTissue DonorsCord Blood Stem Cell TransplantationGraft SurvivalKidney TransplantationCell TransplantationMyeloablative AgonistsBusulfanHistocompatibility TestingRecurrenceMultiple MyelomaWhole-Body IrradiationCombined Modality TherapyRemission InductionMelphalanRetrospective StudiesImmunosuppressive AgentsHistocompatibilityHematopoietic Stem Cell MobilizationGraft vs Leukemia EffectHeart TransplantationPluripotent Stem CellsLeukemiaTransplantation ImmunologyLung TransplantationNeural Stem CellsStem Cell NicheDisease-Free SurvivalTime FactorsVidarabineSurvival RateSurvival AnalysisMesenchymal Stromal CellsAntigens, CD34Graft RejectionCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsHepatic Veno-Occlusive DiseaseSalvage TherapyLeukemia, Myeloid, AcuteInduced Pluripotent Stem CellsOrgan TransplantationChimerismGraft vs Tumor EffectTransplantation, IsogeneicHLA AntigensSiblingsLymphocyte TransfusionHematologic DiseasesMyelodysplastic SyndromesFollow-Up StudiesTransplantationMultipotent Stem CellsLymphoma, Non-HodgkinIslets of Langerhans TransplantationAntilymphocyte SerumImmunosuppressionGranulocyte Colony-Stimulating FactorPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow CellsCell LineageLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFetal Stem CellsHematopoiesisCytomegalovirus InfectionsLymphocyte DepletionCells, CulturedUnrelated DonorsCytarabineStem Cell FactorHodgkin DiseaseLiving DonorsPrognosisAnemia, AplasticPancreas TransplantationT-LymphocytesAcute DiseaseFlow CytometryEtoposideCyclosporineCell ProliferationLeukapheresis